Torthaí cuardaigh - Hans‐Henrik Parving

Beachtaigh na torthaí
  1. 1
    Diabetic nephropathy: Prevention and treatment

    Diabetic nephropathy: Prevention and treatment de réir Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension

    Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension de réir Hans‐Henrik Parving, Finn Gyntelberg

    Foilsithe / Cruthaithe 1973
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Diabetic Nephropathy

    Diabetic Nephropathy de réir Lionel H. Opie, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Genetics of diabetic nephropathy.

    Genetics of diabetic nephropathy. de réir Hans‐Henrik Parving, Lise Tarnow, Peter Rossing

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients

    Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients de réir Peter Rossing, Philip Hougaard, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study

    Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study de réir Peter Rossing, Philip Hougaard, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria

    Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria de réir Steen Andersen, Jens Brøchner‐Mortensen, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients

    Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients de réir Per K. Christensen, Henrik Post Hansen, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Microalbuminuria as an Early Marker for Cardiovascular Disease

    Microalbuminuria as an Early Marker for Cardiovascular Disease de réir Dick de Zeeuw, Hans‐Henrik Parving, Robert H. Henning

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

    Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review de réir Frederik Persson, Morten Lindhardt, Peter Rossing, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy

    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy de réir Peter Hovind, Lise Tarnow, Per B. Oestergaard, Hans Henrik Parving

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy

    Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy de réir Kasper Rossing, Peter Karl Jacobsen, Lotte Pietraszek, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

    Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes de réir Peter Gæde, Henrik Lund‐Andersen, Hans‐Henrik Parving, Oluf Pedersen

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes de réir Hans‐Henrik Parving, Hiddo J. Lambers-Heerspink, Dick de Zeeuw

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

    Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria de réir Steen Andersen, Harald Mischak, Petra Zürbig, Hans‐Henrik Parving, Peter Rossing

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

    Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy de réir Peter Hovind, Lise Tarnow, Peter Rossing, Bendix Carstensen, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

    Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study de réir M.-A. Gall, Philip Hougaard, K. Borch‐Johnsen, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Progression of diabetic nephropathy

    Progression of diabetic nephropathy de réir Peter Hovind, Peter Rossing, Lise Tarnow, U. Smidt, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients

    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients de réir Hans-Henrik Parving, E. Hommel, Berit R. Jensen, Henrik Post Hansen

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378

    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378 de réir Peter Hovind, Peter Rossing, Lise Tarnow, U. Smidt, Hans‐Henrik Parving

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: